Background. Although the prevalence of non-B non-C hepatocellular carcinoma (NBNC HCC) has increased, its clinicopathologic characteristics remain unclear. Methods. We retrospectively analyzed 518 HCC patients who underwent hepatic resection. Hepatitis B surface antigen-and hepatitis C antibody-negative patients were categorized into the NBNC HCC group (n = 145); others were categorized into the hepatitis B or C HCC (BC HCC) group (n = 373). We subdivided the etiologies of NBNC HCC according to alcohol intake and presence of steatosis. Results. NBNC HCC was associated with nonalcoholic fatty liver disease (NAFLD) (13.1 %), fatty liver disease with moderate alcohol intake (9.0 %), alcoholic liver disease (ALD) (29.7 %), cryptogenic disease (44.1 %), and other known etiologies (4.1 %). The prevalence of obesity, diabetes mellitus, and hypertension was higher and hepatic function was better in the NBNC HCC group, which had significantly larger tumors than the BC HCC group. The entire NBNC HCC group displayed similar overall and disease-free survival as the BC HCC group. Among the subdivisions, NAFLD-associated HCC patients had significantly better disease-free survival than ALD-associated HCC and BC HCC patients. Microvascular invasion (hazard ratio [HR] 2.30; 95 % confidence interval [CI] 1.33-3.96) and steatosis area\5 % of noncancerous region (HR 2.13; 95 % CI 1.21-3.93) were associated with disease-free survival in NBNC HCC patients. Conclusions. The prognosis of NBNC HCC was similar to that of BC HCC. Among NBNC HCC patients, NAFLDassociated HCC patients had a relatively low recurrence risk. Absence of steatosis in hepatic parenchyma had a significant impact on disease-free survival in NBNC HCC patients.
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Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third most frequent cause of cancer-related death worldwide. 1, 2 Liver cirrhosis is the primary risk factor for HCC development, which is the long-term result of chronic hepatitis B (HBV) or hepatitis C virus (HCV) infection or chronic alcohol consumption. [3] [4] [5] [6] [7] Recently, the prevalence of hepatitis B surface antigen (HBsAg)-and hepatitis C antibody (HCVAb)-negative HCC-also termed non-B non-C HCC (NBNC HCC)-has rapidly increased, whereas that of HBV-or HCV-related HCC has decreased due to antiviral therapy. [8] [9] [10] [11] The etiology of NBNC HCC is multifactorial and remains unorganized. In addition to chronic alcohol consumption, nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome-related factors (i.e., obesity, insulin resistance, diabetes mellitus, dyslipidemia, and hypertension) are considered risk factors for NBNC HCC.
fatty liver disease with moderate alcohol consumption (intake, 20-70 g ethanol/day, 2.5 %), primary biliary cirrhosis (8.0 %), other biliary cirrhosis (0.8 %), autoimmune hepatitis (6.8 %), metabolic disease (0.6 %), congestive disease (0.8 %), parasitic disease (0.2 %), other known etiology (0.2 %), and unknown etiology (10.5 %) were identified as the causes of non-B non-C liver cirrhosis. 17 Chronic alcohol consumption, obesity-associated metabolic syndrome, and their common pathological consequences characterized by steatosis are considered essential etiological factors for categorizing NBNC HCC. Studies have examined the clinicopathologic characteristics of NBNC HCC; however, none systematically categorized NBNC HCC patients based on etiology and pathology of hepatic parenchyma.
These etiological factors may be closely associated with tumor characteristics, preoperative hepatic functional reserve, and the resulting surgical outcomes of NBNC HCC patients. We investigated the clinicopathologic features and prognostic factors of NBNC HCC patients who underwent hepatic resection. We categorized their etiology based on alcohol consumption, metabolic syndrome prevalence, and pathology of underlying parenchymal change, especially focusing on presence of steatosis, which is a key etiological criterion of NBNC HCC.
PATIENTS AND METHODS

Patients
Between January 2000 and December 2011, 688 HCC patients underwent initial hepatic resection at our institution. We excluded 170 patients because the pathological findings of fibrosis and steatosis in the parenchyma were not precisely evaluated. The remaining 518 patients were divided into 2 groups: patients negative for HBsAg and HCVAb were categorized into the NBNC HCC group (n = 145); others were included in the HBV-or HCVrelated HCC (BC HCC) group (n = 373). NBNC HCC patients were further categorized according to the etiological criteria of the nationwide survey of non-B non-C liver cirrhosis in Japan at the 15th General Meeting of the Japan Society of Hepatology as: (1) ALD, with heavy alcohol consumption (ethanol intake [70 g/day); (2) NAFLD, characterized by histological fatty liver without chronic alcohol consumption (ethanol intake B20 g/day); (3) FLD, also characterized by histological fatty liver and moderate alcohol consumption (ethanol intake, 20-70 g/day); (4) other known etiology (e.g., autoimmune hepatitis, cholestatic diseases, or other chronic liver diseases); and (5) cryptogenic diseases. 17 Among the conventional cryptogenic HCC cases, we tentatively established the following criteria of non-steatotic and metabolic syndrome-associated HCC (Non-steatotic Met HCC): daily ethanol intake \70 g/day; absence of the pathological steatosis; and prevalence of one or more of metabolic syndrome-associated risk factors. The definitions of the risk criteria for metabolic syndrome were based on the international criteria with slight modification to suit the Japanese criteria as follows: obesity (body mass index [25 kg/m 2 ); diabetes mellitus (fasting glucose C126 mg/ dL or HbA1c C6.5 %); dyslipidemia (increased triglycerides C150 mg/dL or reduced HDL cholesterol \40 mg/dL in men or \50 mg/dL in women); and hypertension (systolic C130 and/or diastolic C85 mmHg). 16, 18 Drug treatment for diabetes, dyslipidemia, or hypertension was an alternative indicator.
This study was in accordance with the ethical guidelines for epidemiological research in Japan and was approved by the Ethics Committee of the Kyoto University Graduate School and Faculty of Medicine (approval code: E2029).
Data Collection
History of alcohol intake was collected using an interview-sheet, and the data were confirmed by the participants' families, doctors, and nurses. The indocyanine green retention rate at 15 min (ICG R15) was measured as a marker of preoperative liver function. Serum alphafetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) levels were measured before surgical treatment. Surgical complications were classified according to the Clavien-Dindo classification. 19, 20 In addition to pathological tumor characteristics, the pathological findings of noncancerous liver tissue were evaluated. Presence of steatosis was defined according to the amount of surface area involved by fatty infiltration: none, \5, 5-33, and [33 %. Even in cases with minimum steatosis (steatosis \5 %), patients were diagnosed as positive for steatosis. NBNC HCC patients with steatosis were further assessed according to their NAFLD activity score (NAS). 21 Liver fibrosis progression was recorded using the Metavir score; F4 was defined as pathological cirrhosis. 22 
Statistical Analysis
Categorical variables were presented as numbers and percentages. Continuous variables were presented as mean ± standard deviation. Differences in categorical variables were analyzed using the chi-squared or Fisher's exact test; continuous variables were compared using the Mann-Whitney U test. Median survival and 95 % confidence intervals (95 % CIs) were determined using the Kaplan-Meier method; groups were compared using the log-rank test. Variables that were associated with survival at p \ 0.10 in univariate survival analysis were included in a multivariate Cox regression analysis, and hazard ratios (HRs) and 95 % CIs were calculated. In all analyses, p \ 0.05 was considered statistically significant. JMP 10 software (SAS Institute Inc., Cary, NC) was used in all statistical analyses.
RESULTS
Etiology of NBNC HCC
The proportion of NBNC HCC patients who underwent surgical resection has recently increased ( Fig. 1) . The etiology of NBNC HCC was multifactorial and complex, and we conventionally categorized patients according to the alcohol intake level and presence of pathological steatosis (Fig. 2) . ALD (n = 43, 29.7 %) was a major cause of disease, followed by NAFLD (n = 19, 13.1 %) and FLD (n = 13, 9.0 %), which were commonly characterized by steatosis without alcohol intake and steatosis with moderate alcohol intake, respectively. Despite the complexity of the etiological criteria, [40 % of cases of NBNC HCC were categorized as cryptogenic HCC (n = 64, 44.1 %). In such conventional cryptogenic cases, we tentatively established the criteria of non-steatotic met HCC: absence of heavy alcohol intake; absence of steatosis; and presence of metabolic syndrome-associated risk factors, including obesity, diabetes mellitus, dyslipidemia, or hypertension ( Fig. 2) . non-steatotic met HCC patients (n = 43) accounted for 29.7 % of all NBNC HCC cases and represented more than half of all cases originally categorized as cryptogenic HCC. Among the six patients with other known etiologies (4.1 %), four had autoimmune hepatitis, one had primary biliary cirrhosis, and one had Budd-Chiari syndrome.
Clinicopathologic Characteristics of NBNC HCC
The clinicopathologic characteristics of the NBNC HCC and BC HCC groups were examined (Table 1) . Age, body mass index, and the prevalence of diabetes mellitus and hypertension were significantly higher among NBNC HCC patients than among BC HCC patients. The NBNC HCC group had a greater proportion of patients with low alcohol intake (ethanol intake B20 g/day) and more patients who were heavy drinkers (ethanol intake [70 g/day), reflecting the etiological criteria of ALD and NAFLD. The hepatic functional reserve based on the Child-Pugh classification and ICG R15 and other liver damage indicators (e.g., transaminase and albumin levels, prothrombin activity, and platelet count) were better in the NBNC HCC group. Larger tumor size and higher serum DCP levels were preoperative tumor characteristics of the NBNC HCC group, whereas serum AFP levels were lower among these patients. The number of tumors, presence of microvascular invasion, and TNM stage were not significantly different between the two groups. Moreover, NBNC HCC patients were less likely to have fibrosis and more likely to display steatosis than BC HCC patients. The NBNC HCC group had more patients who underwent major hepatectomy; thereby, the surgical time was longer in this group. Surgical blood loss and the rate of operative complications did not differ significantly between the groups.
Furthermore, we examined the characteristics of each subdivision of NBNC HCC group (Supplemental Table 1 tumors, and they were characterized by higher DCP levels, and a higher rate of poorly differentiated tumor and microvascular invasion than non-steatotic met HCC patients.
We additionally examined the NAS of NAFLD-associated HCC patients (Supplemental Fig. 1 ) as NAFLD ranges from simple steatosis to NASH. The diagnosis of NAFLD was made according to NAS C3, including possible NASH cases. The characteristics of these patients were assessed (Supplemental Table 2 ). The high NAS group had more advanced tumors than the low NAS group, but liver function and the prevalence of cirrhosis did not differ significantly. BMI and the rate of obesity were significantly higher in the low NAS group.
Survival Analysis of Patients with NBNC HCC and BC HCC
The median overall survival times of the NBNC HCC (n = 145) and BC HCC groups (n = 373) were 78.5 (95 % CI 59.9-85.5) and 72.4 months (95 % CI 58.4-81.4), respectively (p = 0.436). The median disease-free survival times among patients in the NBNC HCC (n = 126) and BC HCC groups (n = 304) who underwent curative resection were 24.5 (95 % CI 19.5-33.8) and 20.5 months (95 % CI 17.6-25.3), respectively (p = 0.2953). Prognosis in the two groups did not differ significantly. Among the various etiologies, the overall and disease-free survival rates of NAFLD-associated HCC patients were better than those of ALD-associated HCC and BC HCC patients (see Supplemental Figs. 2 and 3) . On the other hand, the prognosis of Non-Steatotic Met HCC and cryptogenic HCC was similarly as poor as that of ALD-associated HCC or BC HCC. Table 2 presents the results of univariate and multivariate analyses of the disease-free survival of NBNC HCC patients who underwent curative resection. Alcohol intake levels and the prevalence of obesity, diabetes, or dyslipidemia were not associated with disease-free survival. Although several studies reported that serum hepatitis B core (HBc) antibody positivity, also termed ''occult hepatitis B virus infection,'' is a risk factor for NBNC HCC, we did not identify significant involvement of HBc antibody positivity in the risk of NBNC HCC recurrence. 8, 23, 24 Multivariate analysis revealed that the presence of microvascular invasion and steatosis area \5 % of noncancerous region were significantly associated with disease-free survival after curative resection (Table 2) . However, liver cirrhosis did not significantly affect the recurrence risk among NBNC HCC patients.
Impact of Steatosis on Disease-Free Survival
Liver cirrhosis is a powerful risk factor for HCC development, and it was consistent with the disease-free survival of BC HCC patients in our study (Supplemental Fig. 4) . In NBNC HCC patients, liver cirrhosis did not affect the recurrence risk (Supplemental Fig. 5 ). On the other hand, the absence of steatosis was associated with the disease-free survival of NBNC HCC patients (Supplemental Fig. 6 ), but not with that of BC HCC patients (Supplemental Fig. 7) . The relationship between steatosis area and disease-free survival is shown in Fig. 3 and suggests that a lesser extent of steatosis led to a higher risk of HCC progression.
To assess the possibility that the absence of steatosis might be a consequence of liver fibrosis progression, thus explaining the poor prognosis of NBNC HCC patients, we analyzed the correlations between steatosis and liver fibrosis. Liver fibrosis was scored in NBNC HCC patients with steatosis area C5 % (n = 39) as: F0, 25.6 %; F1, 20.5 %; F2, 18.0 %; F3, 10.3 %; and F4, 25.6 %. Conversely, liver fibrosis in NBNC HCC patients with steatosis area \5 % (n = 95) was categorized as: F0, 20.7 %; F1, 34.0 %; F2, 13.2 %; F3, 12.3 %; and F4, 19.8 %. No Significant p values \ 0.05 are shown in bold Data represent the mean ± standard deviation or the number of patients NBNC HCC non-B non-C hepatocellular carcinoma, BC HCC hepatitis B virus-or hepatitis C virus-related hepatocellular carcinoma, BMI body mass index, ICG R15 indocyanine green retention rate at 15 min, AST aspartate aminotransferase, ALT alanine aminotransferase, AFP alphafetoprotein, DCP des-gamma-carboxy prothrombin correlationsbetween the extent of steatosis and the progression of fibrosis were found.
DISCUSSION
Recently, the prevalence of NBNC HCC has rapidly increased. 11, 25 NAFLD and NASH, the major causes of NBNC HCC, are associated with metabolic syndrome risk factors. 13, 16, [26] [27] [28] The epidemic rise in obesity and metabolic syndrome might explain the increase in the NBNC HCC prevalence in Japan and Western countries. Our study showed that the proportion of NBNC HCC patients who underwent surgical resection also has increased. The prevalence of obesity, diabetes mellitus, and hypertension was higher among NBNC HCC patients than among BC HCC patients, suggesting that obesity and metabolic syndrome are important risk factors for NBNC HCC. The tumor sizes of the NBNC HCC group were significantly larger than those of the BC HCC group. As their hepatic function was relatively preserved, NBNC HCC patients were frequently diagnosed incidentally or symptomatically without follow-up for their liver damage, possibly resulting in tumor progression at the time of detection. The higher serum DCP levels of NBNC HCC patients might be related with the larger tumor size of these patients, whereas the lower serum AFP levels implied less progression of liver damage. [29] [30] [31] [32] Major hepatectomy was frequently performed among NBNC HCC patients because of the large tumor size and good hepatic function reserve. Our survival analysis after surgical treatment revealed no significant difference in prognosis between the two groups, suggesting that the better hepatic functional reserve of NBNC HCC patients is offset by their more advanced tumors.
Multivariate survival analysis revealed that microvascular invasion and smaller steatosis area in the parenchyma were associated with the disease-free survival of NBNC HCC patients. Interestingly, pathological steatosis had a stronger effect on the recurrence risk after curative resection than pathological liver fibrosis, which is the strongest predisposing factor for HCC development. 1, 3, 4 Our study indicated that the absence of steatosis, but not its promotion, was involved in higher recurrence risk. Patients with NAFLD-associated HCC had a significantly lower recurrence risk than patients with ALD-associated HCC and BC HCC. However, the recurrence risks of Non-Steatotic Met HCC patients, who did not fulfill the pathological criteria for NAFLD but exhibited metabolic syndrome-associated risk factors, were not different from those of ALD-associated HCC and BC HCC patients. Absence of steatosis in the NBNC HCC background might indicate the presence of somewhat chronic liver damage not characterized by the promotion of liver fibrosis.
This study has several potential limitations. First, selfreports on alcohol intake might be inaccurate. However, we attempted to overcome such a limitation by using a questionnaire form and verifying patient reports with doctors, nurses, and families. Second, the presence of steatosis was based on focal observation of the noncancerous region of the resected liver tissue and it did not necessarily represent the characteristics of the entire underlying parenchymal changes. Third, the prevalence of obesity and metabolic syndrome in the Japanese population differs from that of Western countries, and so we had to partially modify the international diagnostic criteria of obesity and metabolic syndrome.
In conclusion, chronic alcohol consumption, metabolic syndrome, and their common pathological consequence (i.e., steatosis) are risk factors for NBNC HCC development. Absence of steatosis had a stronger impact on disease-free survival than liver fibrosis in NBNC HCC patients. In postoperative surveillance and lifestyle education, we should devote more attention to such patients with NBNC HCC and those who lack steatosis in the parenchyma. 
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